1130379

Biogen, Inc. — FEI 1220951

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 1, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)